Matinas BioPharma Holdings Reverse Stock Split
Matinas BioPharma implemented a one-for-fifteen (1:15) reverse stock split of its common stock effective September 28, 2026. The split was previously approved by stockholders at the 2025 annual meeting and is intended to adjust the share price for continued trading on the NYSE American.